Safety limits of antidepressant use plus combinations: focus on cardiovascular function (2018)
- Authors:
- Autor USP: FORLENZA, ORESTES VICENTE - FM
- Unidade: FM
- DOI: 10.2174/1389200219666171227203225
- Subjects: SEROTONINA; DOENÇAS CARDIOVASCULARES; ANTIDEPRESSIVOS; PLACEBOS; INFARTO DO MIOCÁRDIO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Current drug metabolism
- ISSN: 1389-2002
- Volume/Número/Paginação/Ano: v. 19, n. 8, p. 641-652, 2018
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- Versão do Documento: Versão submetida (Pré-print)
-
Status: Artigo possui versão em acesso aberto em repositório (Green Open Access) -
ABNT
STELLA, Florindo et al. Safety limits of antidepressant use plus combinations: focus on cardiovascular function. Current drug metabolism, v. 19, n. 8, p. 641-652, 2018Tradução . . Disponível em: https://doi.org/10.2174/1389200219666171227203225. Acesso em: 15 mar. 2026. -
APA
Stella, F., Loureiro, J. C., Pais, M. V., Canineu, P. R., & Forlenza, O. V. (2018). Safety limits of antidepressant use plus combinations: focus on cardiovascular function. Current drug metabolism, 19( 8), 641-652. doi:10.2174/1389200219666171227203225 -
NLM
Stella F, Loureiro JC, Pais MV, Canineu PR, Forlenza OV. Safety limits of antidepressant use plus combinations: focus on cardiovascular function [Internet]. Current drug metabolism. 2018 ; 19( 8): 641-652.[citado 2026 mar. 15 ] Available from: https://doi.org/10.2174/1389200219666171227203225 -
Vancouver
Stella F, Loureiro JC, Pais MV, Canineu PR, Forlenza OV. Safety limits of antidepressant use plus combinations: focus on cardiovascular function [Internet]. Current drug metabolism. 2018 ; 19( 8): 641-652.[citado 2026 mar. 15 ] Available from: https://doi.org/10.2174/1389200219666171227203225 - Neuroprotective Effects of Lithium: Implications for the Treatment of Alzheimer’s Disease and Related Neurodegenerative Disorders
- Cognitive impairment in remitted late -life depression is not associated with Alzheimer's disease -related CSF biomarkers
- Caregiver burden regarding elderly with bipolar disorder [Editorial]: An underrecognized problem
- Noninvasive brain stimulation for behavioural and psychological symptoms of dementia: a systematic review and meta-analysis
- Sensitivity and specificity of a briefer version of the Cambridge Cognitive Examination (CAMCog-Short) in the detection of cognitive decline in the elderly: An exploratory study
- Systemic Inflammation and Multimodal Biomarkers in Amnestic Mild Cognitive Impairment and Alzheimer's Disease
- Social skills and well-being among family caregivers to patients with Alzheimer's disease
- Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project
- An intervention to reduce neuropsychiatric symptoms and caregiver burden in dementia: preliminary results from a randomized trial of the tailored activity program-outpatient version
- What are the reasons for the repeated failures of clinical trials with anti-amyloid drugs for AD treatment? [Editorial]
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
